Targeting the cytoskeleton with an FDA approved drug to promote recovery after spinal cord injury
- PMID: 29752944
- DOI: 10.1016/j.expneurol.2018.05.007
Targeting the cytoskeleton with an FDA approved drug to promote recovery after spinal cord injury
Comment on
-
Systemic administration of epothilone D improves functional recovery of walking after rat spinal cord contusion injury.Exp Neurol. 2018 Aug;306:243-249. doi: 10.1016/j.expneurol.2017.12.001. Epub 2017 Dec 7. Exp Neurol. 2018. PMID: 29223322
-
Systemic epothilone D improves hindlimb function after spinal cord contusion injury in rats.Exp Neurol. 2018 Aug;306:250-259. doi: 10.1016/j.expneurol.2018.01.018. Epub 2018 Feb 2. Exp Neurol. 2018. PMID: 29408734
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
